Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). (Q53352094)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

review article

1 reference

stated in

Europe PubMed Central

title

Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

author name string

E Holme

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

S Lindstedt

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

publication date

1 August 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

published in

Journal of Inherited Metabolic Disease

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

volume

21

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

page(s)

507-517

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

cites work

Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurologic crises in hereditary tyrosinemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady state kinetics of 4-hydroxyphenylpyruvate dioxygenase from human liver (III)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The occurrence of hepatoma in the chronic form of hereditary tyrosinemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the enzymic defects in hereditary tyrosinemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-induced correction of the genetic defect in tyrosinemia type I

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and management of tyrosinemia type I.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete Rescue of Lethal Albino c Mice by Null Mutation of 4-Hydroxyphenylpyruvate Dioxygenase and Induction of Apoptosis of Hepatocytes in These Mice by in VivoRetrieval of the Tyrosine Catabolic Pathway

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of 4-Hydroxyphenylpyruvate Dioxygenase by 2-(2-Nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-Chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation in nine Spanish patients with tyrosinaemia type I

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9728331

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1023/A:1005410820201

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

Dimensions Publication ID

1027020476

0 references

PubMed publication ID

9728331

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9728331

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/9728331

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53352094&oldid=2212087671"